Skip to main content
. 2024 Aug 8;25(8):280. doi: 10.31083/j.rcm2508280

Table 2.

Logistic regression of baseline characteristics associated with LVEF improvement.

Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Age 1.00 (0.99–1.01) 0.329 0.99 (0.97–1.01) 0.283
Sex (male) 0.99 (0.75–1.30) 0.923 1.08 (0.66–1.76) 0.773
Ultrasound interval 0.97 (0.96–0.99) <0.001 0.95 (0.93–0.96) <0.001
Alcohol consumption history 0.61 (0.43–0.86) 0.005 0.47 (0.28–0.78) 0.004
NYHA class III–IV 0.43 (0.31–0.59) <0.001 0.28 (0.15–0.52) <0.001
Coronary heart disease 1.53 (1.18–1.99) 0.001 0.98 (0.58–1.63) 0.938
Dilated cardiomyopathy 0.47 (0.33–0.65) <0.001 0.47 (0.26–0.84) 0.012
Hypertension 1.69 (1.31–2.19) <0.001 1.53 (1.02–2.29) 0.040
Diabetes 1.54 (1.16–2.04) 0.003 0.94 (0.60–1.48) 0.794
β-blockers 1.53 (1.17–2.00) 0.002 2.29 (1.54–3.43) <0.001
Uric acid 0.998 (0.997–0.999) <0.001 0.999 (0.997–1.000) 0.046
PDW 0.94 (0.89–0.99) 0.026 1.07 (0.98–1.16) 0.141
PCT 16.64 (2.92–98.13) 0.002 20.02 (0.89–510.93) 0.065

Abbreviations: NYHA, New York Heart Association; PDW, platelet distribution width; PCT, plateletocrit; LVEF, left ventricular ejection fraction; OR, odds ratio; CI, confidence interval.